Immuneering Corporation (IMRX) Tops Q3 EPS by 3c

Immuneering Corporation (NASDAQ: IMRX) reported Q3 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• NPR retracts story about Justice Alito retiring from Supreme Court
• Intel (INTC) August calls active, share price up 4%
• AMD (AMD) call put ratio 1.7 calls to 1 put as share price up 3.2%